Thus, not only tumor cells of distinct genetic background and distinct histotype origin can become immunogenic when expressing CIITA-driven MHC class II molecules (31, 43) but they can also do so by presenting relevant and sufficient tumor derived-peptides within a single MHC-II restricting element, the IA molecule. This evidence concerns the gene CIITA and neoplasm.